Rossmore Private Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Sell |
18,550
-31
| -0.2% | -$2.43K | 0.17% | 104 |
|
|
2025
Q1 | $1.35M | Sell |
18,581
-263
| -1% | -$19.1K | 0.17% | 102 |
|
|
2024
Q4 | $1.4M | Sell |
18,844
-10
| -0.1% | -$740 | 0.17% | 98 |
|
|
2024
Q3 | $1.24M | Sell |
18,854
-500
| -3% | -$33K | 0.15% | 108 |
|
|
2024
Q2 | $1.79M | Sell |
19,354
-241
| -1% | -$22.3K | 0.23% | 82 |
|
|
2024
Q1 | $1.87M | Sell |
19,595
-140
| -0.7% | -$13.4K | 0.25% | 82 |
|
|
2023
Q4 | $1.5M | Sell |
19,735
-10
| -0.1% | -$763 | 0.21% | 92 |
|
|
2023
Q3 | $1.37M | Sell |
19,745
-66
| -0.3% | -$4.57K | 0.21% | 89 |
|
|
2023
Q2 | $1.87M | Hold |
19,811
| – | – | 0.28% | 73 |
|
|
2023
Q1 | $1.64M | Sell |
19,811
-3,200
| -14% | -$265K | 0.26% | 78 |
|
|
2022
Q4 | $1.58M | Sell |
23,011
-10
| -0% | -$688 | 0.25% | 79 |
|
|
2022
Q3 | $1.9M | Hold |
23,021
| – | – | 0.34% | 71 |
|
|
2022
Q2 | $2.19M | Hold |
23,021
| – | – | 0.38% | 65 |
|
|
2022
Q1 | $2.71M | Hold |
23,021
| – | – | 0.42% | 64 |
|
|
2021
Q4 | $2.98M | Sell |
23,021
-70
| -0.3% | -$9.07K | 0.47% | 59 |
|
|
2021
Q3 | $2.61M | Sell |
23,091
-254
| -1% | -$28.8K | 0.45% | 60 |
|
|
2021
Q2 | $2.42M | Sell |
23,345
-265
| -1% | -$27.4K | 0.41% | 61 |
|
|
2021
Q1 | $1.98M | Hold |
23,610
| – | – | 0.37% | 67 |
|
|
2020
Q4 | $2.15M | Sell |
23,610
-618
| -3% | -$56.4K | 0.44% | 61 |
|
|
2020
Q3 | $1.93M | Buy |
+24,228
| New | +$1.93M | 0.45% | 61 |
|
|
2020
Q2 | – | Sell |
-17,082
| Closed | -$1.07M | – | 172 |
|
|
2020
Q1 | $1.07M | Buy |
+17,082
| New | +$1.07M | 0.37% | 67 |
|